ERSTE STOCK BIOTEC CZK R01 (VTA)/ AT0000A0XYP0 /
| NAV18/06/2024 | Chg.-123.4697 | Type de rendement | Focus sur l'investissement | Société de fonds |
|---|---|---|---|---|
| 12,921.4805CZK | -0.95% | Full reinvestment | Equity Sector Biotechnology | Erste AM ▶ |
Performance mensuelle
| janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | 6.06 | 4.16 | 10.68 | 6.33 | 6.48 | -3.18 | 9.10 | -0.85 | 5.31 | -3.70 | 14.90 | -0.11 | +68.77% |
| 2014 | 12.51 | 7.09 | -15.75 | -0.83 | 6.52 | 6.14 | 2.72 | 10.21 | 3.08 | 8.36 | 2.83 | 4.26 | +54.28% |
| 2015 | 13.35 | 6.10 | 6.20 | -5.52 | 8.29 | -3.77 | 6.63 | -8.60 | -17.49 | 15.60 | 7.12 | -3.47 | +20.88% |
| 2016 | -26.81 | -0.46 | -5.58 | 9.99 | 2.48 | -7.17 | 12.53 | -2.01 | 3.27 | -6.46 | 11.85 | -5.24 | -18.75% |
| 2017 | 0.76 | 10.07 | -1.92 | 0.03 | -9.50 | 6.57 | 0.61 | -0.21 | 3.38 | -5.11 | -3.78 | 4.84 | +4.26% |
| 2018 | 1.06 | -2.65 | -3.71 | 1.49 | 9.13 | 2.51 | 1.78 | 8.83 | -1.35 | -13.87 | 3.63 | -12.89 | -8.63% |
| 2019 | 17.96 | 8.95 | -4.32 | -1.15 | -3.39 | 2.85 | 2.67 | -4.75 | -5.49 | 4.67 | 12.57 | 0.51 | +32.21% |
| 2020 | -4.95 | -3.10 | 1.79 | 13.10 | 3.35 | -0.76 | -6.21 | -5.86 | 5.55 | 1.10 | -3.74 | 2.42 | +1.02% |
| 2021 | 2.95 | -2.57 | -3.18 | -1.71 | -5.90 | 8.49 | -2.10 | 4.33 | -3.20 | -0.62 | -2.47 | -1.83 | -8.33% |
| 2022 | -12.69 | -0.85 | 3.92 | -0.32 | -4.16 | 3.20 | 5.87 | 0.71 | 2.08 | 5.49 | -2.64 | -3.90 | -4.73% |
| 2023 | -1.17 | -3.04 | -2.68 | 1.25 | 1.37 | -1.55 | 1.30 | 1.65 | -0.01 | -6.19 | -0.99 | 15.10 | +3.72% |
| 2024 | 1.73 | 6.29 | -2.90 | -6.30 | -1.42 | 4.83 | - | - | - | - | - | - | - |
Valeurs calculées
| CAD | 6 Mois | 1 An | 3 Ans | 5 Ans | |
|---|---|---|---|---|---|
| Volatilité | 16.06% | 16.82% | 16.81% | 21.24% | 24.26% |
| Ratio de Sharpe | 0.00 | 0.32 | 0.21 | -0.25 | -0.14 |
| Le meilleur mois | +15.10% | +15.10% | +15.10% | +15.10% | +15.10% |
| Le plus défavorable mois | -6.30% | -6.30% | -6.30% | -12.69% | -12.69% |
| Perte maximale | -11.78% | -11.78% | -11.78% | -27.51% | -35.30% |
| Surperformance | -1.94% | - | -7.59% | -30.56% | -29.75% |
Toutes les cotations dans CZK
Tranches
| Nom | Type de rendement | Prix de rachat | 1 An | 3 Ans | |
|---|---|---|---|---|---|
| ERSTE Stock Biotec D02 VTIA | Full reinvestment | 2,952.7500 | +7.30% | -4.47% | |
| ERSTE Stock Biotec D02 VTIA | Full reinvestment | 49,467.3398 | +10.64% | +12.89% | |
| ERSTE Stock Biotec D02 VTIA | Full reinvestment | 122.0200 | +3.80% | -0.81% | |
| ERSTE Stock Biotec D01 A | paying dividend | 118.9800 | +3.14% | -1.45% | |
| ERSTE Stock Biotec D01 T | reinvestment | 118.0500 | +3.15% | -1.44% | |
| ERSTE STOCK BIOTEC HUF R01 (VTA) | Full reinvestment | 207,151.4219 | +9.55% | +10.01% | |
| ERSTE STOCK BIOTEC CZK R01 (VTA) | Full reinvestment | 12,921.4805 | +7.24% | -4.55% | |
| ERSTE STOCK BIOTEC EUR R01 (VTA) | Full reinvestment | 522.5800 | +3.14% | -1.47% | |
| ERSTE STOCK BIOTEC EUR R01 (A) | paying dividend | 476.0500 | +3.15% | -1.46% | |
| ERSTE STOCK BIOTEC EUR R01 (T) | reinvestment | 476.0200 | +3.15% | -1.46% |
Performance
| CAD | +1.66% | ||
|---|---|---|---|
| 6 Mois | +4.46% | ||
| 1 An | +7.24% | ||
| 3 Ans | -4.55% | ||
| 5 Ans | +1.05% | ||
| 10 ans | +60.99% | ||
| Depuis le début | +188.62% | ||
| Année | |||
| 2023 | +3.72% | ||
| 2022 | -4.73% | ||
| 2021 | -8.33% | ||
| 2020 | +1.02% | ||
| 2019 | +32.21% | ||
| 2018 | -8.63% | ||
| 2017 | +4.26% | ||
| 2016 | -18.75% | ||
| 2015 | +20.88% | ||
